Human LR³ insulin-like Growth Factor-I (LR³IGF-I) was developed by GroPep Bioreagents specifically for supplementation of mammalian cell culture to support the survival and proliferation of cells. This LR³IGF-I Rapid™ ELISA kit combines GroPep’s expertise in the field of IGF research and Biosensis’ newly established Rapid™ ELISA platform.
GroPep Bioreagents will attend the 7th International Congress of the GRS and IGF Society in Singapore, 15 – 18 October 2014. We are a Silver Sponsor of the meeting.
Hope you enjoyed the meeting. Looking forward to 2016.